Is an irregular menstrual cycle normal in a 43-year-old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Irregular Menstrual Cycles in a 43-Year-Old Woman

Irregular menstrual cycles are normal in a 43-year-old woman and likely represent perimenopause, the transition period before menopause characterized by fluctuating hormone levels. 1, 2

Understanding Perimenopause

  • Perimenopause typically occurs between ages 42-52 and is clinically determined by the onset of irregular menstrual cycles or variable cycle lengths 3
  • Women commonly transition from having regular cycles to irregular cycles before reaching their final menstrual period 4
  • Irregular cycles are defined as menstrual cycles less than 21 days or more than 35 days in length 5, 6
  • In late perimenopause, anovulation becomes more common, leading to skipped menstrual cycles 4

Hormonal Changes During Perimenopause

  • Perimenopause is characterized by fluctuating hormone levels rather than an orderly decline in ovarian function 2
  • FSH levels increase while estradiol levels may remain normal or even elevated during early perimenopause 1, 2
  • Inhibin B (a product of small antral follicles) decreases, contributing to the rise in FSH 2
  • These hormonal fluctuations lead to unpredictable menstrual patterns 1
  • Both ovulatory and anovulatory cycles can occur during this transition period 2

Clinical Features of Perimenopausal Bleeding

  • Shorter follicular phases (11±2 days vs. 14±1 days in younger women) leading to shorter overall menstrual cycles 1
  • Potential for heavier or prolonged bleeding episodes 7
  • Increased frequency of anovulatory cycles in the 30 months before final menstruation 2
  • Possible hyperestrogenism, hypergonadotropism, and decreased luteal phase progesterone 1

When to Seek Medical Evaluation

  • Heavy or prolonged bleeding that is considered abnormal should prompt medical evaluation 7
  • If clinically indicated, underlying gynecological problems should be considered, including:
    • Sexually transmitted infections 7
    • Pregnancy (though less likely at age 43) 7
    • Pathologic uterine conditions such as polyps or fibroids 7
  • Laboratory tests that may be useful include complete blood count and coagulation studies 7

Management Options

  • For unacceptable heavy or prolonged bleeding, NSAIDs for short-term treatment (5-7 days) may be effective 7
  • Low-dose oral contraceptive pills can decrease menstrual blood loss and improve cycle regularity 4
  • Hormonal treatments such as low-dose combined oral contraceptives may be considered for short-term management (10-20 days) if medically eligible 7
  • Tranexamic acid may reduce menstrual blood loss, though caution is needed in women with thromboembolic disease 7

Health Implications

  • Irregular menstruation is considered an important health indicator among women 6
  • Women are at increased risk of depression and anxiety during perimenopause 3
  • Menstrual irregularity has been associated with various conditions including metabolic syndrome, coronary heart disease, and type 2 diabetes mellitus 6
  • Vaginal dryness is a common symptom, particularly in late perimenopause 4

Important Considerations

  • There is no specific endocrine marker that reliably indicates the stage of menopausal transition, making FSH or estradiol measurements unreliable for determining proximity to menopause 2
  • The transition to menopause is highly variable between individuals 2
  • Perimenopausal symptoms may persist for several years before reaching menopause (defined as 12 consecutive months without menstruation) 4, 2

References

Research

Characterization of reproductive hormonal dynamics in the perimenopause.

The Journal of clinical endocrinology and metabolism, 1996

Research

Genitourinary symptoms in the menopausal transition.

The American journal of medicine, 2005

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Abnormal Menstrual Bleeding Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.